KCT0008498
Recruiting
未知
A study for the collection of clinical data for stroke patients and normal adults.
Ministry of Science and ICT0 sites290 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Ministry of Science and ICT
- Enrollment
- 290
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Stroke patient group
- •\- 20 years of age or older
- •\- Patients with stroke onset \=1 month
- •\- Patients with an NIHSS score of 1 or greater to 20 or less
- •\- After receiving a detailed explanation of the study and fully understanding it, the subject or his/her legal representative has voluntarily decided to participate and has given written consent to comply with the precautions.
- •Normal adult group
- •\- 20 years of age or older
- •\- Able to perform independent activities of daily living
- •\- After receiving a detailed explanation of the study and fully understanding it, the subject has voluntarily decided to participate and has given written consent to comply with the precautions.
Exclusion Criteria
- •Stroke patient group
- •\- Patients with systemic infectious disease at the time of study entry
- •\- Patients with impaired capacity to consent (MMSE less than 10\) who are not accompanied by a caregiver.
- •\- Subjects with severe internal medical conditions, including unstable conditions of the cardiovascular, digestive, respiratory, and endocrine systems, who are in poor general condition.
- •\- Any other condition that the investigator considers inappropriate for participation in this study.
- •(Patients who are participating in other clinical trials or studies, or who have participated in other clinical trials or studies within the past 30 days, may be eligible to participate in this study).
- •Normal adult group
- •Patients with 1 or more of the following are not eligible to participate in the study
- •\- Scoring below normal for age and education on the K\-MoCA (Korean version of the Montreal Cognitive Assessment) test.
- •\- Subjects with Residual disability due to brain disease (stroke, brain tumor, cerebral palsy, dementia, Parkinson's disease, etc.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Study for acquiring extended data on the clinical applicability of AllergoEye” (an AI-based software, CE certified) for the automatic redness determination of the sclera of the eye based on photographs. AllergoEye” as an aid in evaluating results of the conjunctival provocation test (KPT)J30.1Allergic rhinitis due to pollenDRKS00033338Praxis für HNO und Allergologie Dr. Yury Yarin47
Active, not recruiting
Not Applicable
Clinical Study to gain information about the function of program to facilitate dosing of a long acting insuliType 2 diabetes mellitus receiving BOT Therapy or insulin therapy onlyMedDRA version: 14.1Level: PTClassification code 10067585Term: Type 2 diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersTherapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Therapeutic techniques [E02]EUCTR2011-005806-32-DEikfe GmbH
Not yet recruiting
Not Applicable
Acquisition of clinical data and investigation for the development of artificial intelligence (AI) in the diagnosis of subepithelial lesion -prospective cohort studyJPRN-UMIN000050718agoya University720
Active, not recruiting
Not Applicable
A clinical study to generate a set of data characterising clinical events, physiological responses, and innate and adaptive immune responses following a single intramuscular immunisation with FluadTM seasonal influenza vaccine or saline as placebo control in healthy adults.EUCTR2014-003543-35-BEGhent University Hospital
Not yet recruiting
Not Applicable
Data collection clinical studies, including pharyngeal imaging, in patients with seasonal influenza or COVID-19Seasonal influenza COVID-19JPRN-UMIN000052896Medical Corporation, Shoseikai, Fukuda Internal Medicine4,600